Clinical trial
The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
NCT03122158 is registered in ClinicalTrials.gov with Erzurum Regional Training & Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect and Reliability of Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
- Lead sponsor
- Erzurum Regional Training & Research Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 8, 2017
- Completion date
- December 15, 2018
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.